We have located links that may give you full text access.
Endoscopic silicone injection for female stress urinary incontinence due to intrinsic sphincter deficiency: impact of coexisting urethral mobility on treatment outcome.
Urology 2002 December
OBJECTIVES: To evaluate periurethral silicone injection in the treatment of female stress urinary incontinence due to intrinsic sphincter deficiency (ISD) and assess whether coexisting urethral hypermobility has an impact on treatment outcome.
METHODS: A total of 29 female patients with stress urinary incontinence underwent endoscopic periurethral silicone injection. Using abdominal leak point pressure measurement, ISD was shown preoperatively in all cases. In addition, urethral hypermobility was demonstrated in 14 cases by cotton-swab testing. Treatment outcome was assessed at 3 and 24 months by questionnaire and classified as cure, improvement, or failure.
RESULTS: The morbidity of the procedure was minimal. The median follow-up was 29 months (range 24 to 36). For the entire group, the cure rate was 55% and 45% at 3 and 24 months, respectively. Depending on the existence of urethral hypermobility, the treatment outcome differed significantly. At 3 months, cure was achieved in 73% of the patients with pure ISD and in 36% with urethral hypermobility (P = 0.04). At 24 months, 67% with pure ISD remained continent, but only 21% with urethral hypermobility (P = 0.02).
CONCLUSIONS: In our experience, periurethral silicone injection was a safe treatment for female stress urinary incontinence and provided a moderately successful and durable therapeutic effect in those with sphincter deficiency and good anatomic support. Unsatisfactory results in those with both anatomic incontinence and sphincter deficiency highlight the need for careful preoperative assessment of urethral mobility to exclude such patients from injection therapy.
METHODS: A total of 29 female patients with stress urinary incontinence underwent endoscopic periurethral silicone injection. Using abdominal leak point pressure measurement, ISD was shown preoperatively in all cases. In addition, urethral hypermobility was demonstrated in 14 cases by cotton-swab testing. Treatment outcome was assessed at 3 and 24 months by questionnaire and classified as cure, improvement, or failure.
RESULTS: The morbidity of the procedure was minimal. The median follow-up was 29 months (range 24 to 36). For the entire group, the cure rate was 55% and 45% at 3 and 24 months, respectively. Depending on the existence of urethral hypermobility, the treatment outcome differed significantly. At 3 months, cure was achieved in 73% of the patients with pure ISD and in 36% with urethral hypermobility (P = 0.04). At 24 months, 67% with pure ISD remained continent, but only 21% with urethral hypermobility (P = 0.02).
CONCLUSIONS: In our experience, periurethral silicone injection was a safe treatment for female stress urinary incontinence and provided a moderately successful and durable therapeutic effect in those with sphincter deficiency and good anatomic support. Unsatisfactory results in those with both anatomic incontinence and sphincter deficiency highlight the need for careful preoperative assessment of urethral mobility to exclude such patients from injection therapy.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app